Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Situs Cancer Research Center was a Rogers, Arkansas-based organization that presented itself as a non-profit clinical research entity focused on oncology. The center primarily investigated the use of high-dose intravenous ascorbic acid (Vitamin C) as a treatment for various solid tumors and hematological malignancies, including colorectal and pancreatic cancers. However, the organization was revealed to be a front for a sophisticated fraud scheme led by James W. Bolt, involving the illegal acquisition of millions of dollars in unclaimed assets. In 2013, the facility was raided by the FBI, and Bolt was subsequently sentenced to federal prison for wire fraud, mail fraud, and money laundering. Consequently, the center's clinical programs were terminated or withdrawn, and the organization is no longer active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Situs Cancer Research Center.